4//SEC Filing
SATO VICKI L 4
Accession 0001714899-24-000217
CIK 0001714899other
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 4:43 PM ET
Size
4.8 KB
Accession
0001714899-24-000217
Insider Transaction Report
Form 4
SATO VICKI L
Director
Transactions
- Sale
Common Stock
2024-11-07$30.00/sh−1,020$30,600→ 111,056 total
Footnotes (2)
- [F1]The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 21, 2024.
- [F2]Includes 5,967 unvested RSUs.
Documents
Issuer
Denali Therapeutics Inc.
CIK 0001714899
Entity typeother
Related Parties
1- filerCIK 0001197020
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 4:43 PM ET
- Size
- 4.8 KB